Andrew Venteicher was named director of the Center for Cranial Base Surgery at the University of Minnesota Medical School’s Department of Neurosurgery and the Masonic Cancer Center, where he will be leading key research initiatives in the genomics of brain tumors.
The Oncologic Drugs Advisory Committee held its first session since President Trump’s inauguration, with a two-day, back-to-back marathon meeting, signaling a return to business at FDA after significant upheaval at the agency.
